Evgen Pharma (GB:TCF) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
In a major shift of voting rights, Seneca Partners Limited has reported a decrease from 5.93% to 3.81% in its stake in Theracryf PLC. The notification, dated April 30, 2024, details the change that occurred on April 4, 2024, reflecting the new total of 16,301,456 voting rights held by Seneca Partners. This development could indicate strategic adjustments by the shareholder within the UK-based company.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.